Table 1.
The basic characteristic of the included studies.
| Row | Study | Objectives of the reviews | Name and timeframe of databases searched | No. and types of primary studies | Country | Quality score | Sample size and characteristics |
|---|---|---|---|---|---|---|---|
| 1 | Gavriatopoulou et al.1 | Assessing of cardiac complications between the survivors and non-survivours |
PubMed, Scopus, and Web of Science; December 1, 2019 - April 16, 2020. |
22 studies; case-series (18), cohort(4) |
China (22) | High | 4157 patients. |
| 2 | Shafi et al.2 | Incidence of AMI in COVID-19 patients | MEDLINE, EMBASE, and Cochrane; The onset of the outbreak- August 2020 |
N/R | China (22), Italy(1), Iran (2), South Korea(1), USA(1) | High | 8971 patients |
| 3 | Wang et al.3 | Exploring the clinical characteristics of patients with COVID-19 | PubMed, Embase, WanFang, Chinese Biomedical Literature Database and China National Knowledge Infrastructure databases; January 1, 2020 - April 12, 2020, |
40 studies, all retrospective | England(25),Chinese(15), America(2) | High | 2459 patients |
| 4 | Madjid et al.4 | Determining potential risk factors of cardiac injury in COVID-19-infected patients | Pubmed, Embase, and CNKI databases. December 1, 2019 - May 2, 2020 |
17 studies, all retrospective | All China | High | 5726 patients. |
| 5 | Qiu et al.5 | Risk factors for the COVID-19 related death | PubMed, Embase, medRxiv, and Cochrane Library; January 1, 2020 - April 13, 2020. |
15 articles/N/R | N/R | Moderate | 2401survivours and 904 non-survivours |
| 6 | Zhou et al.6 | To identify the symptoms, comorbidities, radiological features, and outcomes in COVID-19 patients. |
MEDLINE, EMBASE, and OVID; the onset of the outbreak - 26 April 2020 |
45 studies, 40 retrospective cohort studies, 2 prospective cohort studies, 1 cross-sectional study, and 2 cohort studies of unclear design. |
All from China except for two studies from the United States and one multicentre European (Belgium, France, Italy, and Spain) |
High | 14 358 patients. |
| 7 |
Chen et al.7 |
Evaluating the clinical characteristics of patients with severe disease and non-severe cases with COVID-19. | PubMed, Web of Science, MEDLINE, CNKI (China Knowledge Resource Integrated Database), and the Cochrane; December 1, 2019 - February 12, 2020 |
5 Descriptive Studies |
All China |
High | 5328 patients |
| 8 | Shi et al.8 | N/R | N/R | 12 cohort studies | N/R | Low | 2445 patients |
| 9 | Huang et al.9 | Exploring the incidence of cardiac injury and the association between cardiac injury poor outcomes in patients with COVID-19 | PubMed, the Cochrane Library, Embase, and MedRxiv databases; December 2, 2019 - June 5, 2020 |
43 studies, 27 were retrospective cohort studies and the remaining 16 were cross-sectional |
40 in China, one in Korea, and two in the USA |
High | 9475 patients |
| 10 | Babapoor-Farrokhran et al.10 | Comparing of disease outcomes between the severe (ICU) group and non-severe (non-ICU) | PubMed, Embase, and Cochrane; December 5, 2019 - April 14, 2020. |
12 cohort studies | All in China | High | 2445 patients |
| 11 | Tajbakhsh et al.11 | Assessing of subsequent cardiovascular complications and clinical events |
Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, Embase, COVID-19, ClinicalTrials.gov, and EU Clinical Trial Register; December 2019 - July 2020 |
220 unique publications; retrospective (197), randomized controlled trials (13), and prospective(20) | China (47.7%) or the USA (20.9%); 9.5% were from Italy | High | – |
| 12 | Cheng et al.12 | Assessing of cardiac complications in COVID-19 patients between “deceased” and “recovered” patients | PubMed and Embase; December 2019 - April 2020 |
54 studies; 19 records were case reports, case series, or pathological reports |
N/R | High | N/R |
| 13 | Fried et al.13 | Assessing of the association between COVID-19 and cardiovascular complications. |
PubMed and Embase; December 1, 2019 – November 30, 2020 |
12 studies | N/R | Moderate | 3044 patients |
| 14 | Tavazzi et al.14 | N/R | MEDLINE, Embase, Cochrane Database of Systematic Reviews, Scopus, and Web of Science; December 2019 - April 2020 |
13 observational studies | N/R | Moderate | 49,076 patients; 10,009 severe cases and 7773 non-severe cases |
| 15 | Salamanca et al.15 | Investigating the relationship between AMI and mortality risk in COVID-19 patients |
MEDLINE, Scopus and Web of Science; up to 10 April 2020 |
9 studies, N/R | N/R | Moderate | 1686 patients |
| 16 | Zeng et al.16 | Investigating the incidence, comorbidities, outcomes, and possible mechanisms of acute miyocardial injury in COVID-19 patients. |
PubMed and Embase; January 1, 2020, - May 30, 2020 |
16 studies, Prospective(2), Retrospective (14) |
China(14), Italy(1), and the United States (1) |
High | 2224 patients |
| 17 | Sun et al.17 | Evaluating arrhythmia in patients with severe and non-severe COVID-19 |
PubMed, Embase, Web of Science, and the Cochrane Library; December 2019 - July 25, 2020 |
5 studies, (N/R) | N/R | Moderate | 1553 patients, 349 severely ill and 1204 non-severely ill |
| 18 | Stefanini et al.18 | Analyzing the effect of COVID-19 on acute miyocardial injury |
Medline/PubMed, Scopus, and Google Scholar; December 2019 - March 25, 2020 |
11 studies, all cross-sectional designs |
All China | High |
1394 patients |
| 19 | Tondas et al.19 | Assessing electrocardiographic (ECG) ventricular repolarization indices in patients with COVID-19. | PubMed, EuropePMC, SCOPUS, Cochrane Central Database, and Google Scholar; N/R |
2 studies, two case-control | N/R |
moderate |
241 patients |
| 20 | Libby et al20 | Assessing the prevalence of cardiac complications and the resulting mortality rate in COVID-19 patients |
Medline (using PubMed), Embase, Scopus, and Web of Science, Google and Google scholar; 2019 until April 30th, 2020 |
40 studies, Two: One: Ambispective, four: prospective, 35 studies were retrospective |
the United States, one: Spain, one: Italy, the Rest: China |
High | 15,616 patients |
| 21 | Prasitlumkum et al.21 | Assessing cmorbidities in COVID-19 patients. | PubMed, Embase, medRxiv, and SSRN; Dec 1, 2019 - October 14, 2020, | 29 studies | China 10, Iran 1, German 1, Italy 6, turkey 1, us 5, France 1, Israel 1, spine 1 | High | 3508 patients |
| 22 | Zhong et al.22 | Evaluating the incidence of cardiac arrhythmias in patients with COVID-19 |
PubMed, SCOPUS, Europe PMC, Cochrane Central Databases, and Google Scholar þ Preprint Servers; N/R |
4 studies/ all Observational Retrospective |
N/R | Moderate | 784 patients |
| 23 | Zeng et al.23 | Assessing incidence rate of arrhythmia |
PubMed and Embase; July 25, 2020 - September 15, 2020, |
56 studies, Retrospective (46), Cross-sectional(2), Prospective (5) | N/R | Moderate | 17,435 patients |
| 24 | Bennett et al.24 | N/R | MEDLINE, Embase, and The Cochrane library;2019 - 27 May 2020 |
Seventeen retrospective cohort studies | N/R | Moderate | 5815 patients |
| 25 | Huang et al.25 | Prevalence of cardiovascular complications in ICU-admitted COVID-19 patients |
PubMed and Web of Science; up to November 25, 2020 | 29 studies, 5 prospective cohort studies, 1 prospective cross-sectional study, and 20 retrospective cohort studies |
China 15, USA 7, Italy 2, Spain 1, Thailand1, South Korea1, Denmark1 |
High | 4381 patients |
| 26 | Sinclair et al.32 | Comparing cardiac injuries among different viruses | PubMed and EMBASE; December 2019 - August 29, 2020 |
57 studies including | N/R | Moderate | 34,072 patients |
N/R= not reported.